Pulmonx Statistics
Share Statistics
Pulmonx has 40.26M
shares outstanding. The number of shares has increased by 2.53%
in one year.
| Shares Outstanding | 40.26M |
| Shares Change (YoY) | 2.53% |
| Shares Change (QoQ) | 0.78% |
| Owned by Institutions (%) | 91.33% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 597 |
| FTD / Avg. Volume | 0.14% |
Short Selling Information
The latest short interest is 1.19M, so 3% of the outstanding
shares have been sold short.
| Short Interest | 1.19M |
| Short % of Shares Out | 3% |
| Short % of Float | 4.23% |
| Short Ratio (days to cover) | 3.98 |
Valuation Ratios
The PE ratio is -4.71 and the forward
PE ratio is -2.35.
Pulmonx's PEG ratio is
0.47.
| PE Ratio | -4.71 |
| Forward PE | -2.35 |
| PS Ratio | 3.17 |
| Forward PS | 0.4 |
| PB Ratio | 3.09 |
| P/FCF Ratio | -8.05 |
| PEG Ratio | 0.47 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Pulmonx.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.58,
with a Debt / Equity ratio of 0.66.
| Current Ratio | 5.58 |
| Quick Ratio | 4.88 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | -1.11 |
| Debt / FCF | -1.71 |
| Interest Coverage | -16.45 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $287,934.71 |
| Profits Per Employee | $-193,793.81 |
| Employee Count | 291 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 1.29 |
Taxes
| Income Tax | 500K |
| Effective Tax Rate | -0.89% |
Stock Price Statistics
The stock price has increased by -64.81% in the
last 52 weeks. The beta is 0.65, so Pulmonx's
price volatility has been higher than the market average.
| Beta | 0.65 |
| 52-Week Price Change | -64.81% |
| 50-Day Moving Average | 5.81 |
| 200-Day Moving Average | 6.6 |
| Relative Strength Index (RSI) | 27.86 |
| Average Volume (20 Days) | 421,425 |
Income Statement
In the last 12 months, Pulmonx had revenue of 83.79M
and earned -56.39M
in profits. Earnings per share was -1.44.
| Revenue | 83.79M |
| Gross Profit | 62M |
| Operating Income | -57.7M |
| Net Income | -56.39M |
| EBITDA | -50.79M |
| EBIT | -52.39M |
| Earnings Per Share (EPS) | -1.44 |
Full Income StatementBalance Sheet
The company has 70.91M in cash and 56.47M in
debt, giving a net cash position of 14.43M.
| Cash & Cash Equivalents | 70.91M |
| Total Debt | 56.47M |
| Net Cash | 14.43M |
| Retained Earnings | -467.56M |
| Total Assets | 150.74M |
| Working Capital | 98.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -31.54M
and capital expenditures -1.45M, giving a free cash flow of -32.98M.
| Operating Cash Flow | -31.54M |
| Capital Expenditures | -1.45M |
| Free Cash Flow | -32.98M |
| FCF Per Share | -0.84 |
Full Cash Flow StatementMargins
Gross margin is 74%, with operating and profit margins of -68.87% and -67.3%.
| Gross Margin | 74% |
| Operating Margin | -68.87% |
| Pretax Margin | -66.71% |
| Profit Margin | -67.3% |
| EBITDA Margin | -60.62% |
| EBIT Margin | -68.87% |
| FCF Margin | -39.37% |
